Erin Burnett

发表

A microRNA-regulated and GP64-pseudotyped lentiviral vector mediates stable expression of FVIII in a murine model of Hemophilia A.

L. Naldini, M. Ozelo, B. Brown, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Pathologic mechanisms of type 1 VWD mutations R1205H and Y1584C through in vitro and in vivo mouse models.

D. Lillicrap, Kate Sponagle, C. Notley, 2011, Blood.

Immunoglobulin isotypes and functional anti‐FVIII antibodies in response to FVIII treatment in Balb/c and C57BL/6 haemophilia A mice

M. Othman, D. Lillicrap, C. Hough, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia A.

Kirk W. Johnson, D. Lillicrap, A. Labelle, 2008, Blood.

cytokine production to favor a Th1 response by a regulatory CD4+CD25+-dependent mechanism and by shifting Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice

D. Lillicrap, C. Hough, A. Labelle, 2013 .

Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4+CD25+-dependent mechanism and by shifting cytokine production to favor a Th1 response.

P. Thompson, D. Lillicrap, C. Hough, 2009, Blood.

cytokine production to favor a Th 1 response-dependent mechanism and by shifting + CD 25 + by a regulatory CD 4 Anti-CD 3 prevents factor VIII inhibitor development in hemophilia A mice

P. Thompson, D. Lillicrap, C. Hough, 2008 .

Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4 (cid:1) CD25 (cid:1) -dependent mechanism and by shifting cytokine production to favor a Th1 response

P. Thompson, D. Lillicrap, C. Hough, 2008 .

Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice.

M. Othman, D. Lillicrap, C. Hough, 2009, Blood.

Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice.

M. Othman, D. Lillicrap, C. Hough, 2009, Blood.

dogs with hemophilia A Efficacy and safety of a new-class hemostatic drug candidate, AV513, in

Kirk W. Johnson, D. Lillicrap, A. Labelle, 2013 .

Efficacy and Safety of a New-Class of Hemostatic Drug Candidate , AV 513 , in Hemophilia A Dogs

Kirk W. Johnson, D. Lillicrap, A. Labelle, 2007 .